Altimmune Inc (ALT)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Vipin K. Garg |
| Employees: | 50 |
| Web site: | altimmune.com |
|
910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG, MD, 20878
2406541450
| |
-
Formally known as:
- Healthcare Acquisition Corp
Are you looking for this stock instead?
| Date | Ratio |
|---|---|
| 2018-09-14 | 1:30 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Altimmune, Inc. focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis.
Please log in first to see chart